Page 35 - Read Online
P. 35

Ciria et al. Mini-invasive Surg 2024;8:10  https://dx.doi.org/10.20517/2574-1225.2023.126                                                                                     Page 3 of 9



                          Table 1. Summary of studies performing minimally invasive ALPPS

                                                                                      Full                        FLVR hypertrophy         Length of hospital stay         Major complications      90-day mortality
                          Author           Year          ALPPS technique                          EBL (mL)
                                                                                      MIS                         (%)                              (days)                          (%)              (%)
                                                 Stage 1                Stage 2                Stage 1  Stage 2                             Stage 1        Stage 2         Stage 1      Stage 2
                                  [37]
                          Gall et al.      2015 L-RALPPS (n = 4)        O-RH (n = 4)   N       NR        NR       62                        NR             NR              20           NR            0
                                     [38]
                          Truant et al.    2018 L-partial ALPPS (n = 5)  O-REH (n = 5)  N      250       550      60                        7              12              0            40            0
                                  [39]
                          Jiao et al.      2019 L-RALPPS (n = 24)       O-RH (n = 14)   N      310       300      80.7                      9.5            8               3.85         15.3          3.8
                                                 R-RALPPS (n = 2)       L-RH (n = 4)
                                                                        R-RH (n = 1)
                                                                        O-REH (n = 4)
                                                                        L-REH (n = 1)
                                       [20]
                          Machado et al.   2017 L-ALPPS (n = 10)        L-RH (n = 3)   Y       200       320      118                       NR             NR              0            0             0
                                                                        L-REH (n = 7)
                                      [40]
                          Serenari et al.  2020 L-ALPPS (n = 7)         L-RH (n = 2)   Y       NR        NR       62                        6.5            12              14.2         8.3           0
                                                 L-mini-ALPPS (n = 6)   L-REH (n = 5)
                                                 R-ALPPS (n = 1)
                                [41]
                          Li et al.        2021 L-RALPPS (n = 60)       O-RH (n = 32)   N      165       628      45.7                      NR             23.4            13.3         53.3          0
                                                                        O-REH (n = 28)


                          Major complications were defined as Clavien–Dindo classification ≥ IIIA grade. ALPPS: Associated liver partition with portal vein ligation for staged hepatectomy; MIS: minimally invasive surgery; EBL: estimated
                          blood loss; FLRV: future liver remnant volume; RALPPS: radiofrequency-assisted ALPPS; RH: right hepatectomy; REH: right extended hepatectomy; NR: Not Reported; N: not; Y: yes.



                          Clavien–Dindo ≥ IIIA grade complications in stage 1 and 0%-53% in stage 2; and (b) the highest 90-day mortality rate reported was 3.8%. Case selection and

                          indications (HCC vs. CRLM) may influence these outcomes. Moreover, the approach performed during stages is biased. Only the full MIS procedure was
                          performed in two studies      [20,40] . These studies reported a 90-day mortality rate of 0% and a Clavien–Dindo ≥ IIIA grade complication rate of approximately 0%-
                          14.2% in stage 1 and 0%-8.3% in stage 2. Therefore, the evidence supporting minimal invasiveness is weak and mainly supported by case reports or case series,

                          which is a major limitation . Additionally, the heterogeneity among the series concerning the ALPPS techniques performed, indications or approaches in
                                                           [42]
                          different stages makes it challenging to properly evaluate postoperative clinical outcomes. Evidence about open versus modified MI-ALPPS is lacking, making

                          the assessment of the MIS role difficult. Moreover, reports about the robotic approach are limited. Considering these issues, the influence of MIS in ALPPS
                          procedures is still uncertain.



                          HOW I DO A LAPAROSCOPIC ALPPS

                          The ALPPS technique and technical modifications described can be mostly performed by a minimally invasive approach, always in experienced hands. A step-
   30   31   32   33   34   35   36   37   38   39   40